The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage
- 17 March 1994
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 17 (3) , 207-219
- https://doi.org/10.1016/0920-1211(94)90051-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Ketamine, Phencyclidine, and MK‐801 Protect Against Kainic Acid‐Induced Seizure‐Related Brain DamageEpilepsia, 1990
- CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐d‐aspartate receptor antagonists with oral activityBritish Journal of Pharmacology, 1990
- NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsantsEpilepsy Research, 1990
- Phencyclidine, Dizocilpine, and Cerebrocortical NeuronsScience, 1990
- Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonistEpilepsy Research, 1989
- Interactions of benztropine, atropine and ketamine with veratridine‐activated sodium channels: effects on membrane depolarization, K+‐efflux and neutrotransmitter amino acid releaseBritish Journal of Pharmacology, 1988
- The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizuresNeuroscience, 1987
- Prolongation of inhibitory postsynaptic currents by pentobarbitone, halothane and ketamine in CA1 pyramidal cells in rat hippocampusBritish Journal of Pharmacology, 1985
- Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acidEuropean Journal of Pharmacology, 1982
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982